![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1368721
´Ü¹éÁú Á¤Á¦ ¹× ºÐ¸® ½ÃÀå : ±â¼ú, Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº°, ¼¼°è ¿¹Ãø(2023-2032³â)Protein Purification & Isolation Market-Technology [Preparative Chromatography, (Affinity, Ion Exchange), Ultrafiltration], Product [Consumable (Kit, Reagent), Instrument], Application, End-user, Global Forecast 2023 - 2032 |
´Ü¹éÁú Á¤Á¦¡¤ºÐ¸® ½ÃÀå ±Ô¸ð´Â Å©·Î¸¶Åä±×·¡ÇÇ, Àü±â¿µµ¿, ¿©°ú ±â¼úÀÇ Áö¼ÓÀû Áøº¸¿¡ ÀÇÇØ 2023-2032³â CAGR 10.5%·Î È®´ëÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
ºÐ¸® ´É·Â, ¼Óµµ ¹× È®À强 Ãø¸é¿¡¼ ÀÌ·¯ÇÑ ±â¼úÀÇ °³¼±À¸·Î Á¤Á¦ °øÁ¤ÀÌ Å©°Ô Çâ»óµÇ¾î ¿¬±¸ÀÚ¿Í ¹ÙÀÌ¿À Á¦¾à ȸ»ç°¡ ´Ù¾çÇÑ Ä¡·á ¹× Áø´Ü ¿ëµµ·Î °íǰÁúÀÇ ´Ü¹éÁúÀ» ºÐ¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
Àν¶¸°°ú Ç×ü¸¦ Æ÷ÇÔÇÑ ´Ü¹éÁú ÀǾàǰÀÇ »ý»ê·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´Ü¹éÁú Á¤Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶ ºñ¿ë Àý°¨À» À§ÇÑ ¿¬±¸°³¹ß ³ë·Âµµ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 2¿ù MITÀÇ ¿£Áö´Ï¾îµéÀº °³¹ßµµ»ó±¹¿¡¼ ´Ü¹éÁú ÀǾàǰÀ» º¸´Ù Ä£¼÷Çϰí Àú·ÅÇÏ°Ô ¸¸µé±â À§ÇØ ´Ü¹éÁúÀ» ºü¸£°Ô °áÁ¤ÈÇÒ ¼ö Àִ Ư¼ö ³ª³ëÀÔÀÚ¸¦ ¹èÄ¡ÇÏ¿© Á¤Á¦¸¦ ¼öÇàÇÏ´Â »õ·Î¿î ¹æ¹ýÀ» °í¾ÈÇß½À´Ï´Ù.
´Ü¹éÁú Á¤Á¦ ¹× ºÐ¸® »ê¾÷Àº ±â¼ú, Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªÀ¸·Î ±¸ºÐµË´Ï´Ù.
±â¼ú Ãø¸é¿¡¼ Çѿܿ©°ú ºÎ¹® ½ÃÀå °¡Ä¡´Â 2032³â±îÁö Å« °ßÀηÂÀ» °¡Áú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº Á¤Á¦ ¿öÅ©Ç÷ο츦 °£¼ÒÈÇÏ°í ¼ø¼öÇÑ ´Ü¹éÁúÀÇ ³ôÀº ¼öÀ²À» º¸ÀåÇϱâ À§ÇØ ¿À¿° ¹°ÁúÀ» Á¦°ÅÇÏ¸é¼ ´Ü¹éÁúÀ» ¼±ÅÃÀûÀ¸·Î À¯ÁöÇÏ´Â ÀÌ ±â¼úÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²¼º, È®À强 ¹× ¿ÂÈÇÑ ÀÛµ¿ Á¶°Ç¿¡ ´ëÇÑ ¿ä±¸°¡ ±ÞÁõÇÏ¸é¼ ´Ù¾çÇÑ ¹ÙÀÌ¿À ÀǾàǰ ¹× ¿¬±¸ ºÐ¾ß¿¡¼ ÇÑ¿Ü ¿©°ú ±â¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
¿ëµµº°·Î´Â ÀǾàǰ ½ºÅ©¸®´× ºÐ¾ßÀÇ ´Ü¹éÁú Á¤Á¦ ¹× ºÐ¸® »ê¾÷ÀÌ 2022³â Å« ¸ÅÃâÀ» âÃâÇϰí 2032³â±îÁö °·ÂÇÑ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½Å¾à ¿¬±¸°³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀüÀÓ»ó ¹× ÀÓ»ó ¿¬±¸¿ë °íǰÁú Á¤Á¦ ´Ü¹éÁú¿¡ ´ëÇÑ ¿¬±¸ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ Á¤Á¦ ¹× ºÐ¸® ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áúº´ ±âÀü ±Ô¸í ¹× °³ÀÎ ¸ÂÃãÇü Ä¡·áÁ¦ °³¹ß¿¡ Á¤Á¦µÈ ´Ü¹éÁúÀÇ Àû¿ëÀº ÀÌ ºÐ¾ßÀÇ È®ÀåÀ» ´õ¿í °¡¼ÓÈÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Áö¿ªº°·Î º¸¸é À¯·´ÀÇ ´Ü¹éÁú Á¤Á¦ ¹× ºÐ¸® ½ÃÀåÀº źźÇÑ ¹ÙÀÌ¿À Á¦¾à ¹× »ý¸í°øÇÐ ºÐ¾ßÀÇ Á¸Àç·Î ÀÎÇØ 2023-2032³â °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ¿Í °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× Ç¥ÀûÄ¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ °í±Þ ´Ü¹éÁú Á¤Á¦ ¹× ºÐ¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç¿Í Çмú¿¬±¸ ¹× »ê¾÷ Çù·Â¿¡ ´ëÇÑ °ÇÑ ÁýÁßÀº ÀÌ Áö¿ªÀÇ »ê¾÷ Àü¸ÁÀ» È®´ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Protein Purification and Isolation Market size is estimated to expand at 10.5% CAGR from 2023-2032 driven by the continual advancements in chromatography, electrophoresis, and filtration technologies. The improved capabilities of these technologies in terms of resolution, speed, and scalability is significantly enhancing the purification process for enabling researchers and biopharmaceutical companies to isolate high-quality proteins for various therapeutic and diagnostic applications.
The rising rate of manufacturing of protein drugs, including insulin and antibodies is leading to the higher need for purification of protein. The ongoing R&D efforts to help reduce the production costs will also support the market growth. For instance, in February 2023, MIT engineers devised a new way to perform purification by deploying specialized nanoparticles to rapidly crystallize proteins for making protein drugs more accessible and affordable in developing countries.
The protein purification & isolation industry is segmented into technology, product, application, end-user, and region.
With respect to technology, the market value from the ultrafiltration segment is likely to gain significant traction through 2032. The growth can be attributed to the growing adoption of this technology to selectively retain proteins while eliminating contaminants for streamlining the purification workflow and ensuring high yields of pure proteins. Additionally, the surging need for cost-effectiveness, scalability, and gentle operating conditions are contributing to the increasing preference for ultrafiltration technology in various biopharmaceutical and research applications.
In terms of application, the protein purification & isolation industry from the drug screening segment generated substantial revenue in 2022 and is projected to record robust growth through 2032. The increasing focus on drug discovery and development coupled with the rising demand for high-quality purified proteins for preclinical and clinical research is propelling the adoption of advanced purification and isolation techniques. The application of purified proteins in understanding disease mechanisms and developing personalized therapeutics will further accelerate the segment expansion.
Regionally, Europe protein purification & isolation market is set to exhibit robust growth from 2023 to 2032 attributed to the presence of robust biopharmaceutical and biotechnology sectors. Massive investments in R&D activities along with the growing emphasis on personalized medicine and targeted therapeutics are fueling the demand for advanced protein purification and isolation technologies. Moreover, the presence of well-established healthcare infrastructure and the strong focus on academic research and industrial collaborations will augment the regional industry outlook.